Clinical Trials Update: Dec. 7, 2009
2009-Dec-07
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Metastatic Colorectal Cancer
This study is for people with colorectal cancer that has metastasized (spread). The study will evaluate an investigational human monoclonal antibody combined with chemotherapy to see if it extends survival, compared to the best available standard.
The research site is in Beech Grove, Ind.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/colorectal_cancer.aspx.
-----
Treatment Resistant Depression
This study of an investigational medication seeks candidates who have taken antidepressants and were dissatisfied with the results.
The research site is in Seattle, Wash.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
-----
Attention Deficit Hyperactivity Disorder (ADHD)
This study is for adults who have attention deficit hyperactivity disorder (ADHD). Candidates must be aged 18 to 55.
The research site is in Los Alamitos, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/adhd.aspx.
-----
Copyright 2009 ClinicalConnection.com. All rights reserved.
HealthDay News
Copyright © 2009 ScoutNews, LLC. All rights reserved.
The information in this article, including reference materials, are provided to you solely for educational or research purposes. Information in reference materials, are not and should not be considered professional health care advice upon which you should rely. Health care information changes rapidly and consequently, information in this article may be out of date. Questions about personal health should always be referred to a physician or other health care professional.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
